How to Afford Wegovy Without Insurance

Wegovy's list price exceeds $1,350 per month without insurance, but most people paying cash have options to significantly reduce that cost. Novo Nordisk's savings card, patient assistance programs, HSA/FSA accounts, and compounded semaglutide alternatives can each cut your out-of-pocket expense — sometimes to as little as $0 per month if you qualify.

What Does Wegovy Actually Cost Without Insurance?

The retail list price of Wegovy is approximately $1,349–$1,430 per month in the United States as of 2024, depending on your pharmacy. This covers a four-pen supply of your current dose. Because Wegovy requires a dose escalation schedule over 16–20 weeks, your monthly cost may vary by dose tier, though the list price is the same across all doses.

This price does not include the prescriber visit, lab work, or follow-up appointments, which can add $100–$400 per year in additional out-of-pocket costs depending on your provider.

How Does the Novo Nordisk Savings Card Work?

Novo Nordisk, the maker of Wegovy, offers a commercial savings card for eligible patients. According to Novo Nordisk's official savings program, commercially insured patients who still face high out-of-pocket costs may pay as little as $0 per month for a 28-day supply, subject to eligibility limits.

For uninsured patients, the savings card may reduce the monthly cost to approximately $499 per month — a meaningful discount, though still a significant expense. Key details to know:

• You must have a valid prescription from a licensed U.S. prescriber.
• The offer is not valid for patients covered by Medicare, Medicaid, or any federal or state program.
• Eligibility is income-independent for the commercial card — it is not means-tested.
• The savings card is applied at participating pharmacies at the point of sale.

Visit Novo Nordisk's official Wegovy savings page to enroll or confirm current terms, as program details change periodically.

What Is the Dose Escalation Timeline and How Does It Affect Cost?

Wegovy's FDA-approved prescribing information outlines a mandatory 16-week dose escalation before reaching the full maintenance dose of 2.4 mg weekly. Understanding this schedule helps you plan your budget, since each stage uses the same list price but a different pen strength.

What Other Programs Can Help With the Cost?

Patient Assistance Programs (PAPs)

Novo Nordisk's Patient Assistance Program provides free Wegovy to qualifying uninsured or underinsured patients who meet income guidelines. You can apply through NeedyMeds.org, which aggregates manufacturer PAPs, or directly through Novo Nordisk. A prescriber must complete a portion of the application on your behalf.

HSA and FSA Accounts

The IRS classifies Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) as vehicles for qualified medical expenses. Prescription medications, including Wegovy, are eligible expenses under IRS Publication 969. Paying for Wegovy through an HSA or FSA means you use pre-tax dollars, effectively reducing your real cost by your marginal tax rate — typically 22–32% for many working adults.

GoodRx and Discount Cards

GoodRx and similar prescription discount platforms negotiate rates with pharmacy chains. As of 2024, GoodRx prices for Wegovy vary by pharmacy but may offer modest reductions below the retail list price. These discounts generally cannot be combined with the Novo Nordisk savings card — compare both and use whichever is lower at your specific pharmacy.

Telehealth Prescribers

Some telehealth platforms that prescribe GLP-1 medications offer bundled subscription pricing that includes the prescriber visit and access to compound pharmacies (see below), which can reduce the overall cost of treatment significantly compared to traditional in-person care.

Is Compounded Semaglutide a Legal Alternative?

During periods of FDA-declared shortage, compounding pharmacies are legally permitted to produce copies of branded medications including semaglutide. As of early 2025, the FDA has updated its shortage status for semaglutide — meaning compounded versions may no longer be broadly available through all compounders. The FDA's current policy is that compounded semaglutide should only be produced when the branded product is on the official shortage list.

Compounded semaglutide, when available through a legitimate 503A or 503B compounding pharmacy, has been priced significantly below Wegovy — sometimes $200–$500 per month — but it is not FDA-approved and may not have identical safety or efficacy data. Always verify a compounding pharmacy's accreditation through the PCAB (Pharmacy Compounding Accreditation Board) before purchasing.

Frequently Asked Questions

Affording Wegovy without insurance is genuinely difficult, but between the manufacturer savings card, patient assistance programs, HSA/FSA accounts, and compounded alternatives (where legally available), most people have at least one viable path to reduce their costs. The right solution depends on your income, tax situation, and health history — which is exactly why this conversation belongs with your prescriber or a patient advocate who knows your full picture.